Veracyte Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 11.07, above the company average. This is a clear sign of healthy business climate in the Medical Laboratories industry and improving liquidity at their respective customers, during the second quarter 2026. Average receivable collection period, for the Veracyte Inc in Jun 30 2026 quarter, has decreased to 33 days, compared to 34 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 351 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 895 to 2343.

What is Receivable Turnover Ratio?
What is Veracyte Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

VCYT Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	6.62 %	-6.82 %	-4.01 %	-2.01 %	1.01 %
Y / Y Revenue Change	23.45 %	24.79 %	32.81 %	15.07 %	16.07 %
Receivable Turnover Ratio (TTM)	11.07	10.68	9.94	9.17	8.8
VCYT's Total Ranking	# 2343	# 895	# 2175	# 1714	# 1258
Accounts Receivable average collection period days	33	34	37	40	41
Seq. Receivable Change	8.11 %	12.21 %	-6.62 %	-5.88 %	-5.52 %
Seq. Revenue Change	12.05 %	-1.33 %	9.41 %	2.06 %	13.27 %

Receivable Turnover Company Ranking
Within:	No.
Medical Laboratories Industry	# 23
Healthcare Sector	# 352
Overall Market	# 2343

Receivable Turnover Ratio Statistics
High	Average	Low
1.07	0.52	0.2
(Jun 30 2018)		(Dec 31 2021)

VCYT Company Profile • Back to VCYT Efficiency Comparisons • Compare VCYT Receivables Turnover Ratio to its Competitors

Financial Statements
Veracyte Inc 's Accounts Receivable	$ 54 Millions	Visit VCYT's Balance sheet
Veracyte Inc 's Sales TTM	$ 545 Millions	Visit VCYT's Income Statement
Sources of VCYT's Revenues		Visit VCYT's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
VCYT's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
VCYT's Growth Rates	VCYT's Roa	VCYT's Inventory Turnover Ratio	VCYT's Dividend Comparisons
VCYT's Profitability Ratios	VCYT's Roi	VCYT's Asset Turnover Ratio	VCYT's Dividend Growth
VCYT's Valuation Ratios	VCYT's Roe	VCYT's Financial Strength Ratios	VCYT's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Wave Life Sciences Ltd	26.88	$ 81.746 Millions	$ 3.041 Millions
Igc Pharma Inc	26.21	$ 1.101 Millions	$ 0.042 Millions
Sonida Senior Living Inc	23.90	$ 525.973 Millions	$ 22.008 Millions
Marpai Inc	23.52	$ 16.635 Millions	$ 0.707 Millions
Agenus Inc	22.44	$ 132.693 Millions	$ 5.914 Millions
U S Physical Therapy Inc	22.40	$ 812.203 Millions	$ 36.251 Millions
Nutriband Inc	22.15	$ 1.618 Millions	$ 0.073 Millions
Lineage Cell Therapeutics Inc	20.02	$ 13.083 Millions	$ 0.654 Millions
Hims and Hers Health Inc	19.65	$ 2,578.494 Millions	$ 131.228 Millions
Neuraxis Inc	18.95	$ 5.316 Millions	$ 0.281 Millions
China Pharma Holdings Inc	18.55	$ 3.914 Millions	$ 0.211 Millions
Bausch Health Companies Inc	18.42	$ 10,853.000 Millions	$ 589.250 Millions
Arvinas Inc	17.26	$ 316.700 Millions	$ 18.350 Millions
Nrx Pharmaceuticals Inc	17.25	$ 3.394 Millions	$ 0.197 Millions
Polomar Health Services, Inc.	17.19	$ 3.172 Millions	$ 0.185 Millions
Anika Therapeutics Inc	16.70	$ 121.370 Millions	$ 7.266 Millions
Lifemd Inc	16.48	$ 163.363 Millions	$ 9.915 Millions
Longeveron Inc	16.43	$ 1.187 Millions	$ 0.072 Millions
Bioage Labs Inc	15.82	$ 10.355 Millions	$ 0.655 Millions
Vaxart Inc	15.09	$ 243.064 Millions	$ 16.108 Millions
Medicinova Inc	15.02	$ 0.920 Millions	$ 0.061 Millions
Voyager Therapeutics Inc	14.71	$ 34.459 Millions	$ 2.343 Millions
Halozyme Therapeutics Inc	14.68	$ 1,663.738 Millions	$ 113.332 Millions
Nexgel Inc	14.52	$ 11.810 Millions	$ 0.813 Millions
Skinhealth Systems Inc	14.42	$ 289.224 Millions	$ 20.051 Millions
Lftd Partners Inc	14.13	$ 35.335 Millions	$ 2.500 Millions
Talkspace Inc	14.09	$ 246.631 Millions	$ 17.506 Millions
Lifestance Health Group Inc	14.07	$ 1,584.834 Millions	$ 112.665 Millions
10x Genomics Inc	13.90	$ 616.566 Millions	$ 44.342 Millions
Amneal Pharmaceuticals Inc	13.90	$ 3,117.474 Millions	$ 224.342 Millions

Date modified: 2026-09-02T19:45:38+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.